Fritextsökning
Innehållstyper
-
Tror inte på en lyckad affär
Ett eventuellt Pfizer-köp skulle inte löna sig, tror Astazenecas vd Pascal Soriot.
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
Senzagen får vänta på OECD-validering
Myndigheternas granskning och godkännande av Gardskin skjuts upp.
-
Reproducibility and handling in focus with new electronic pipette
The Eppendorf Xplorer electronic pipette has been developed with reproducibility in mind.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
SDU professor helps EU
Mette Præst Knudsen from the University of Southern Denmark, SDU, has been appointed as an expert member in an EU politics group.
-
Studie: Barns immunförsvar anpassade sig till hepatit C-viruset under graviditeten
Forskare vid Karolinska institutet har i en ny studie om nyfödda visat att både smittade och osmittade barn anpassade sig till viruset. Resultaten kan öppna upp...
-
Ny chef på Lif
Rekryterar chef från GSK och regionansvarig från Bayer.
-
Nya skatteregler får börsen att falla
Läkemedelsbolaget Shires aktier störtdök under onsdagen, tillsammans med den sjunkande Europabörsen.
-
Safe and economic dispensing of powders
Mettler Toledo is showcasing Quantos, an automated dispenser for laboratory use.
-
New CEO to Promedvi
Sigrun Axelsson has taken on the leadership of the Lund-based medtech company.
-
Fusion between pharma giants?
It is rumoured that a fusion between Pfizer and Wyeth is in the process of happening.
-
Novo får tummen upp för fetmaläkemedel
Novo Nordisks läkemedelskandidat liraglutide får positiva rekommendationer av FDA:s expertpanel.
-
Finding your way at the fairs
For details on exhibitors, booths, seminars and the fair map we have gathered the important sites for you.
-
Här är hela listan med de svenska ERC-miljonerna
Totalt har 236 forskare fått pengar från det europeiska forskningsrådet ERC. Tolv av dem kommer att arbeta med sina projekt i Sverige.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
NIH-pengar till Umeåforskning
Fredrik Almqvist, Umeå universitet, och hans amerikanska forskarkollega får 24 miljoner kronor från National institutes of health, NIH, till tuberkulosforskning.
-
Ny projektledare på Real Heart
Fredrik Pahlm från ABB Robotics leder utvecklingen av bolagets hjärtpump.
-
Sobis barnstudie igång
Första patienten doserad i fas 1/2-studie med kandidat mot ovanliga Sanfilippos syndrom A.
-
Collaboration brings next generation drugs
Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.
BREAKING